Small & Non-Small Cell Lung Cancer

If you're focusing on this Category and want to learn from the best, then check out the content we have for you.

Proudly supported by

Book My Place

By submitting you agree to the Terms & Privacy Policy

Meet our Speakers

We've gathered some of the top experts in the field to discuss this topic. With years of experience between them, they're well-equipped to offer invaluable insights and perspectives.

Armando Bartolazzi

Armando Bartolazzi

Department of Pathology, Sant’Andrea University Hospital, Rome, Italy

Cara Haymaker

Cara Haymaker

Director, (ORION), UT MD Anderson Cancer Center, Houston, TX, US

Astero Klampatsa

Astero Klampatsa

Thoracic Oncology Immunotherapy Group, The Institute of Cancer Research, London, UK

Andreas Pircher

Andreas Pircher

Medizinische Universität Innsbruck, Innsbruck, Austria

Talks

Overcoming Tumor Antigen Heterogeneity in the Context of CAR T Cell therapy for Solid Tumors

20 September 2021, 09:00 AM
Astero Klampatsa

Tumor Endothelial Cells in NSCLC: headmasters of tumor immunity

20 September 2021, 10:00 AM
Andreas Pircher

Identification of distinct immune signatures in malignant pleural mesothelioma

20 September 2021, 03:00 PM
Cara Haymaker

Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCs

21 September 2021, 09:00 AM
Armando Bartolazzi